Biblio

Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is W and Author is Wysoczynski, Marcin  [Clear All Filters]
2023
Tang X-L, Nasr M, Zheng S, Zoubul T, Stephan JK, Uchida S, Singhal R, Khan A, Gumpert A, Bolli R, et al. Bone Marrow and Wharton's Jelly Mesenchymal Stromal Cells are Ineffective for Myocardial Repair in an Immunodeficient Rat Model of Chronic Ischemic Cardiomyopathy. Stem Cell Rev Rep. 2023.
2021
Tang X-L, Wysoczynski M, Gumpert AM, Li Y, Wu W-J, Li H, Stowers H, Bolli R. Effect of intravenous cell therapy in rats with old myocardial infarction. Mol Cell Biochem. 2021.
Petri BJ, Piell KM, Whitt GCSouth, Wilt AE, Poulton CC, Lehman NL, Clem BF, Nystoriak MA, Wysoczynski M, Klinge CM. HNRNPA2B1 regulates tamoxifen- and fulvestrant-sensitivity and hallmarks of endocrine resistance in breast cancer cells. Cancer Lett. 2021.
2019
Bolli R, Wysoczynski M. Human Embryonic Stem Cell-Derived Cardiomyocytes. Circ Res. 2019;124(8):1157-1159.
2015
Adamiak M, Iv JBMoore, Zhao J, Abdelbaset-Ismail A, Grubczak K, Borkowska S, Wysoczynski M, Ratajczak MZ. Downregulation of heme oxygenase 1 (HO-1) activity in hematopoietic cells enhances their engraftment after transplantation. Cell Transplant. 2015.
Keith MCL, Tang X-L, Tokita Y, Li Q-H, Ghafghazi S, Iv JMoore, Hong KU, Elmore B, Amraotkar A, Ganzel BL, et al. Safety of Intracoronary Infusion of 20 Million C-Kit Positive Human Cardiac Stem Cells in Pigs. PLoS One. 2015;10(4):e0124227.
2014
Wysoczynski M, Hong KU, Moore JB. Bone marrow cell therapies in ischemic cardiomyopathy. Expert Opin Biol Ther. 2014:1-4.